糖尿病肾脏疾病肾性贫血认识与管理中国专家共识（2023年版）解读
Interpretation of Chinese expert consensus on understanding and management of renal anemia in diabetic kidney disease
王伟铭 . 糖尿病肾脏疾病肾性贫血认识与管理中国专家共识（2023年版）解读[J]. 内科理论与实践, 2023 , 18(03) : 137 -140 . DOI: 10.16138/j.1673-6087.2023.03.001
| [1] | Ito K, Yokota S, Watanabe M, et al. Anemia in diabetic patients reflects severe tubulointerstitial injury and aids in clinically predicting a diagnosis of diabetic nephropathy[J]. Intern Med, 2021, 60(9): 1349-1357. |
| [2] | Shams N, Osmani MH. Newly diagnosed anemia in admitted diabetics, frequency, etiology and associated factors[J]. J Coll Physicians Surg Pak, 2015, 25(4): 242-246. |
| [3] | Miulescu RD, Neamtu MC, Margin? D, et al. Associations between thyroid dysfunction and chronic kidney disease[J]. Romanian Journal of Diabetes Nutrition and Metabolic Diseases, 2014, 21(1): 37-42. |
| [4] | Basu G, Mohapatra A. Interactions between thyroid disorders and kidney disease[J]. Indian J Endocrinol Metab, 2012, 16(2): 204-213. |
| [5] | Astor BC, Muntner P, Levin A, et al. Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1994)[J]. Arch Intern Med, 2002, 162(12): 1401-1408. |
| [6] | 许惠婵, 张海红, 刘妙燕. 慢性肾小球肾病与糖尿病肾病维持血液透析患者的贫血对照研究[J]. 中国医药科学, 2012, 2(14): 197-199. |
| [7] | 范秀芳, 王嘉佳, 刁建辉, 等. 糖尿病肾病与非糖尿病肾病贫血的对照研究[J]. 中国当代医药, 2015, 22(24): 35-37. |
| [8] | Camargo JL, Gross JL. Conditions associated with very low values of glycohaemoglobin measured by an HPLC method[J]. J Clin Pathol, 2004, 57(4): 346-349. |
| [9] | Kidney Disease: Improving Global Outcomes KDIGO Anemia Work Group. KDIGO clinical practice guideline for anemia in chronic kidney disease[J]. Kidney Int Suppl, 2012, 2(4):279-335. |
| [10] | Ghoti H, Rachmilewitz EA, Simon-Lopez R, et al. Evidence for tissue iron overload in long-term hemodialysis patients and the impact of withdrawing parenteral iron[J]. Eur J Haematol, 2012, 89(1): 87-93. |
| [11] | Ueda N, Takasawa K. Impact of inflammation on ferritin, hepcidin and the management of iron deficiency anemia in chronic kidney disease[J]. Nutrients, 2018, 10(9): 1173. |
| [12] | Loutradis C, Skodra A, Georgianos P, et al. Diabetes mellitus increases the prevalence of anemia in patients with chronic kidney disease: a nested case-control study[J]. World J Nephrol, 2016, 5(4): 358-366. |
| [13] | 中国医师协会肾脏内科医师分会肾性贫血指南工作组. 中国肾性贫血诊治临床实践指南[J]. 中华医学杂志, 2021, 101(20): 1463-1502. |
| [14] | Kim SH, Lee KA, Jin HY, et al. The relationship between anemia and the initiation of dialysis in patients with type 2 diabetic nephropathy[J]. Diabetes Metab J, 2015, 39(3): 240-246. |
| [15] | Toft G, Heide-J?rgensen U, van Haalen H, et al. Anemia and clinical outcomes in patients with non-dialysis dependent or dialysis dependent severe chronic kidney disease: a Danish population-based study[J]. J Nephrol, 2020, 33(1): 147-156. |
| [16] | O’Mara NB. Anemia in patients with chronic kidney disease[J]. Diabetes Spectr, 2008, 21(1): 12-19. |
| [17] | Aso Y, Suganuma R, Wakabayashi S, et al. Anemia is associated with an elevated serum level of high-molecular-weight adiponectin in patients with type 2 diabetes independently of renal dysfunction[J]. Transl Res, 2009, 154(4):175-182. |
| [18] | Tarng DC. Cardiorenal anemia syndrome in chronic kidney disease[J]. J Chin Med, 2007, 70(10):424-429. |
| [19] | Kliger AS, Foley RN, Goldfarb DS, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for anemia in CKD[J]. Am J Kidney Dis, 2013, 62(5): 849-859. |
| [20] | KDOQI. KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease[J]. Am J Kidney Dis, 2007, 49(2 Suppl 2):S12-S154. |
| [21] | Mikhail A, Brown C, Williams JA, et al. Renal association clinical practice guideline on anaemia of chronic kidney disease[J]. BMC Nephrol, 2017, 18(1):345. |
| [22] | National Institute for Health and Care Excellence. Chronic kidney disease: assessment and management[M/OL]. London: National Institute for Health and Care Excellence (NICE), 2021, https://www.nice.org.uk/guidance/ng203. |
| [23] | Panchapakesan U, Sumual S, Pollock C. Nanomedicines in the treatment of anemia in renal disease: focus on CERA (Continuous Erythropoietin Receptor Activator)[J]. Int J Nanomedicine, 2007, 2(1): 33-38. |
| [24] | Mehdi U, Toto RD. Anemia, diabetes, and chronic kidney disease[J]. Diabetes Care, 2009, 32(7): 1320-1326. |
| [25] | Koulouridis I, Alfayez M, Trikalinos TA, et al. Dose of erythropoiesis-stimulating agents and adverse outcomes in CKD: a metaregression analysis[J]. Am J Kidney Dis, 2013, 61(1): 44-56. |
| [26] | Del Vecchio L, Longhi S, Locatelli F. Safety concerns about intravenous iron therapy in patients with chronic kidney disease[J]. Clin Kidney J, 2016, 9(2): 260-267. |
| [27] | Pfeffer MA, Burdmann EA, Chen CY, et al. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease[J]. N Engl J Med, 2009, 361(21): 2019-2032. |
| [28] | Ritz E, Laville M, Bilous RW, et al. Target level for hemoglobin correction in patients with diabetes and CKD: primary results of the Anemia Correction in Diabetes (ACORD) Study[J]. Am J Kidney Dis, 2007, 49(2):194-207. |
| [29] | Chen N, Hao C, Liu BC, et al. Roxadustat treatment for anemia in patients undergoing long-term dialysis[J]. N Engl J Med, 2019, 381(11): 1011-1022. |
| [30] | Chen N, Hao C, Peng X, et al. Roxadustat for anemia in patients with kidney disease not receiving dialysis[J]. N Engl J Med, 2019, 381(11): 1001-1010. |
| [31] | Zhang L, Liu Y, Huang Y, et al. Effect of roxadustat versus erythropoietin(EPO) for treating anemia in patients with diabetic kidney disease: a retrospective cohort study[J]. Ann Transl Med, 2022, 10(22): 1224. |
| [32] | 中国研究型医院学会肾脏病学专业委员会. 罗沙司他治疗肾性贫血中国专家共识[J]. 中华医学杂志, 2022, 102(24): 1802-1810. |
| [33] | Minutolo R, Garofalo C, Chiodini P, et al. Types of erythropoiesis-stimulating agents and risk of end-stage kidney disease and death in patients with non-dialysis chronic kidney disease[J]. Nephrol Dial Transplant, 2021, 36(2): 267-274. |
| [34] | Spinowitz BS, Kausz AT, Baptista J, et al. Ferumoxytol for treating iron deficiency anemia in CKD[J]. J Am Soc Nephrol, 2008, 19(8): 1599-605. |
| [35] | Shukla R, Mishra N. Management of iron deficiency anemia-recent challenges[J]. Indian J Res, 2015, 4: 100-102. |
| [36] | 中华医学会肾脏病学分会肾性贫血诊断和治疗共识专家组. 肾性贫血诊断与治疗中国专家共识(2018 修订版)[J]. 中华肾脏病杂志, 2018, 34(11): 860-866. |
/
| 〈 |
|
〉 |
